推荐产品
一般說明
IsoStrip小鼠单克隆抗体分型试剂盒是一个简单的三步法试剂盒,可用于快速鉴定小鼠单克隆抗体。
内容物
内容物
- 显影管,含有预先包被抗小鼠Ig抗体的冻干乳胶珠
- 分型试纸条,预先包被亚类和轻链特异性抗小鼠Ig抗体
特異性
与乳胶珠结合的抗小鼠抗体将与任意同种型的小鼠单克隆抗体反应。试纸条上固定的山羊抗小鼠抗体,能与各种常见的小鼠抗体同种型(IgG1、IgG2a、IgG2b、IgG3、IgM和IgA)以及轻链发生特异性结合。
浓度为1.0 μg/ml时,对所有特异性抗体(IgML除外)的特异性:≥ 2
IgM Lambda, 浓度为1.0 μg/ml时:≥ 1
浓度为1.0 μg/ml时,对所有特异性抗体(IgML除外)的特异性:≥ 2
IgM Lambda, 浓度为1.0 μg/ml时:≥ 1
應用
该试剂盒可用于快速鉴定小鼠单克隆抗体(免疫球蛋白)的分类、亚类和轻链类型。
特點和優勢
- 可靠:产生与标准ELISA测定相当的结果
- 快速:从开始到结束仅需5分钟
- 轻松:仅需3个步骤
- 经济:无需任何设备或其他试剂
- 高度特异性:与FBS无交叉反应
包裝
1个试剂盒包含2种组分。
規格
测定时间:5分钟
样品材料:杂交瘤上清液,纯化小鼠单克隆抗体,腹水
样品材料:杂交瘤上清液,纯化小鼠单克隆抗体,腹水
準備報告
工作溶液:稀释样品
- 从罐中取出所需数量的分型试纸条。取下相同数量的显影管的盖子。
可以用铅笔或实验室记号笔标记显影管,方便识别。 - 使用1% BSA/磷酸盐缓冲盐水(PBS)稀释含有小鼠单克隆抗体的样品,pH 7.2至7.6。
培养上清液样品应以1:10至1:100稀释。腹水样品应按1:20,000稀释。这些是推荐稀释度,具体取决于样品中的抗体浓度。根据我们的经验,稀释样品的单克隆抗体
浓度为0.1至1 g/ml时可获得最佳结果。将150ml上述稀释样品加入显影管中。
其他說明
仅用于生命科学研究。不可用于诊断。
法律資訊
IsoStrip is a trademark of Roche
仅试剂盒组分
产品编号
说明
- Development Tubes, containing lyophilized latex beads, precoated with anti-mouse-Ig antibodies
- Isotyping Strips, precoated with subclass- and light-chain-specific anti-mouse-Ig antibodies
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
nwg
閃點(°F)
does not flash
閃點(°C)
does not flash
其他客户在看
Frontiers in immunology, 11, 612402-612402 (2021-01-12)
Better understanding of roles of complement in pathology has fuelled an explosion of interest in complement-targeted therapeutics. The C5-blocking monoclonal antibody (mAb) eculizumab, the first of the new wave of complement blocking drugs, was FDA approved for treatment of Paroxysmal
Cancers, 13(12) (2021-07-03)
The current endoscopy and biopsy diagnosis of esophageal adenocarcinoma (EAC) and its premalignant condition Barrett's esophagus (BE) is not cost-effective. To enable EAC screening and patient triaging for endoscopy, we developed a microfluidic lectin immunoassay, the EndoScreen Chip, which allows
Clinical and vaccine immunology : CVI, 23(8), 681-688 (2016-06-10)
There is a significant need for an effective multivalent Shigella vaccine that targets the most prevalent serotypes. Most Shigella vaccines under development utilize serotype-specific lipopolysaccharides (LPSs) as a major component based on protection and epidemiological data. As vaccine formulations advance
Immunology, 157(4), 283-295 (2019-05-24)
Over the last decade there has been an explosion in complement therapies; one-third of the drugs in the clinic or in development target C5 protein. Eculizumab, a monoclonal antibody (mAb) that binds C5 and blocks its cleavage by the convertase
Frontiers in oncology, 10, 20-20 (2020-03-03)
Antibodies directed against CD22 have been used in radioimmunotherapy (RIT) clinical trials to treat patients with diffuse large B-cell lymphoma (DLBCL) with promising results. However, relevant preclinical models are needed to facilitate the evaluation and optimization of new protocols. Spontaneous
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门